Related Experiment Video
Updated: Jun 13, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression
Junling Si1, Xueyan Yu, Yingjie Zhang
1Department of Veterinary Biosciences, Ohio State University College of Veterinary Medicine, Columbus, Ohio 43210, USA.
Background:
"Loss of function" alterations in CCAAT/Enhancer Binding Proteindelta (C/EBPdelta) have been reported in a number of human cancers including breast, prostate and cervical cancer, hepatocellular carcinoma and acute myeloid leukemia. C/EBPdelta gene transcription is induced during cellular quiescence and repressed during active cell cycle progression. C/EBPdelta exhibits tumor suppressor gene properties including reduced expression in cancer cell lines and tumors and promoter methylation silencing. We previously reported that C/EBPdelta expression is inversely correlated with c-Myc (Myc) expression. Aberrant Myc expression is common in cancer and transcriptional repression is a major mechanism of Myc oncogenesis. A number of tumor suppressor genes are targets of Myc transcriptional repression including C/EBPalpha, p15INK4, p21CIP1, p27KIP1 and p57KIP2. This study investigated the mechanisms underlying Myc repression of C/EBPdelta expression.
Results:
Myc represses C/EBPdelta promoter activity in nontransformed mammary epithelial cells in a dose-dependent manner that requires Myc Box II, Basic Region and HLH/LZ domains. Chromatin Immunoprecipitation (ChIP) assays demonstrate that Myc, Miz1 and Max are associated with the C/EBPdelta promoter in proliferating cells, when C/EBPdelta expression is repressed. EMSAs demonstrate that Miz1 binds to a 30 bp region (-100 to -70) of the C/EBPdelta promoter which contains a putative transcription initiator (Inr) element. Miz1 functions exclusively as a repressor of C/EBPdelta promoter activity. Miz1 siRNA expression or expression of a Miz1 binding deficient Myc (MycV394D) construct reduces Myc repression of C/EBPdelta promoter activity. Max siRNA expression, or expression of a Myc construct lacking the HLH/LZ (Max interacting) region, also reduces Myc repression of C/EBPdelta promoter activity. Miz1 and Max siRNA treatments attenuate Myc repression of endogenous C/EBPdelta expression. Myc Box II interacting proteins RuvBl1 (Pontin, TIP49) and RuvBl2 (Reptin, TIP48) enhances Myc repression of C/EBPdelta promoter activity.
Conclusion:
Myc represses C/EBPdelta expression by associating with the C/EBPdelta proximal promoter as a transient component of a repressive complex that includes Max and Miz1. RuvBl1 and RuvBl2 enhance Myc repression of C/EBPdelta promoter activity. These results identify protein interactions that mediate Myc repression of C/EBPdelta, and possibly other tumor suppressor genes, and suggest new therapeutic targets to block Myc transcriptional repression and oncogenic function.
Insights
The oncogene c-Myc (Myc) represses the tumor suppressor CCAAT/Enhancer Binding Proteindelta (C/EBPdelta) by forming a complex with Max and Miz1 at the C/EBPdelta promoter. This interaction, enhanced by RuvBl1 and RuvBl2, offers potential therapeutic targets for cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- CCAAT/Enhancer Binding Proteindelta (C/EBPdelta) is a tumor suppressor frequently downregulated in various human cancers.
- C/EBPdelta expression is inversely correlated with the oncogene c-Myc (Myc), suggesting Myc-mediated repression.
- Understanding the mechanisms of Myc-driven repression of tumor suppressor genes is crucial for cancer therapy.
Purpose of the Study:
- To investigate the molecular mechanisms by which Myc represses C/EBPdelta expression.
- To identify the specific protein interactions and domains involved in Myc-mediated transcriptional repression of C/EBPdelta.
- To explore potential therapeutic strategies targeting Myc's oncogenic functions.
Main Methods:
- Reporter gene assays to measure C/EBPdelta promoter activity.
- Chromatin Immunoprecipitation (ChIP) to detect protein-DNA interactions at the C/EBPdelta promoter.
- Site-directed mutagenesis of Myc and expression of small interfering RNA (siRNA) for Max and Miz1.
- Electrophoretic Mobility Shift Assays (EMSAs) to analyze protein binding to the C/EBPdelta promoter.
Main Results:
- Myc represses C/EBPdelta promoter activity in a dose-dependent manner, requiring specific Myc domains (Myc Box II, Basic Region, HLH/LZ).
- Myc, Max, and Miz1 associate with the C/EBPdelta promoter in proliferating cells.
- Miz1 binds to a specific region of the C/EBPdelta promoter and acts as a repressor; Max and Miz1 siRNA reduce Myc-mediated repression.
- RuvBl1 and RuvBl2 enhance Myc-mediated repression of C/EBPdelta promoter activity.
Conclusions:
- Myc represses C/EBPdelta by forming a transient repressive complex with Max and Miz1 at the proximal promoter.
- RuvBl1 and RuvBl2 proteins enhance this Myc-mediated repression.
- These findings elucidate key protein interactions in Myc's oncogenic mechanism and suggest novel therapeutic targets.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Abnormal Proliferation
Co-activators and Co-repressors
Co-activators and Co-repressors
Cell Specific Gene Expression

